Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H KLEINMAN

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Transfusion|April 12, 2005
Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003M P Busch, L H Tobler, J Saldanha, et al.
Transfusion|June 1, 1994
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1E Donegan, H Lee, E A Operskalski, et al.
Blood|April 14, 2012
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomesMichael P Busch, Krishna K Murthy, Steven H Kleinman, et al.
AIDS (London, England)|September 10, 2003
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infectionEberhard W Fiebig, David J Wright, Bhupat D Rawal, et al.
The New England Journal of Medicine|February 25, 1988
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibodyJ W Ward, S D Holmberg, J R Allen, et al.
Transfusion|November 20, 2010
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoffDanielle M Carrick, Bryce Johnson, Steven H Kleinman, et al.
The New England Journal of Medicine|November 8, 1990
Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study GroupM P Busch, P E Taylor, B A Lenes, et al.
Molecular Pharmaceutics|November 4, 2014
In silico prediction of pharmaceutical degradation pathways: a benchmarking studyMark H Kleinman, Steven W Baertschi, Karen M Alsante, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
Blood|July 28, 2019
Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusionNareg H Roubinian, Colleen Plimier, Jennifer P Woo, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Transfusion|April 12, 2005
Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003M P Busch, L H Tobler, J Saldanha, et al.
Transfusion|June 1, 1994
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1E Donegan, H Lee, E A Operskalski, et al.
Blood|April 14, 2012
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomesMichael P Busch, Krishna K Murthy, Steven H Kleinman, et al.
AIDS (London, England)|September 10, 2003
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infectionEberhard W Fiebig, David J Wright, Bhupat D Rawal, et al.
The New England Journal of Medicine|February 25, 1988
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibodyJ W Ward, S D Holmberg, J R Allen, et al.
Transfusion|November 20, 2010
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoffDanielle M Carrick, Bryce Johnson, Steven H Kleinman, et al.
The New England Journal of Medicine|November 8, 1990
Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study GroupM P Busch, P E Taylor, B A Lenes, et al.
Molecular Pharmaceutics|November 4, 2014
In silico prediction of pharmaceutical degradation pathways: a benchmarking studyMark H Kleinman, Steven W Baertschi, Karen M Alsante, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
Blood|July 28, 2019
Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusionNareg H Roubinian, Colleen Plimier, Jennifer P Woo, et al.
Pageof 15